ONCOPROTEIN STABILITY AFTER TUMOR RESECTION

被引:21
作者
ONG, G
GULLICK, W
SIKORA, K
机构
[1] ICRF Oncology Group, Hammersmith Hospital, London, W12 OHS, Du Cane Road
关键词
D O I
10.1038/bjc.1990.121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The means by which oncogenes and their products activate malignant tranformation are currently under intense investigation. However, published papers on experiments using human tumour material do not always report in detail their methods of collection or storage of the specimens. In order to assess the stability of oncogene encoded proteins following collection or storage of human tumour biopsies, we have examined the rate of decay of the c-myc, neu and EGF-receptor proteins. Solid tumours, containing amplified copies of each oncogene, were established in nude mice and the stability of the oncogene protein in portions of each tumour, left in phosphate buffered saline at room temperature for varying time intervals, was examined by immunoblotting. Intact EGF-recptor and neu oncoproteins were present even after 24 h under these conditions while the c-myc protein was apparently rapidly degraded after 20 min. These data demonstrate that oncogene products decay at different rates after tumour resection and that collection of human biopsies should take this into account in order to provide the basis for consistent measurements of protein expression. © Macmillan Press Ltd., 1990.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 19 条
  • [1] HOMOGENEOUSLY STAINING CHROMOSOMAL REGIONS CONTAIN AMPLIFIED COPIES OF AN ABUNDANTLY EXPRESSED CELLULAR ONCOGENE (C-MYC) IN MALIGNANT NEUROENDOCRINE CELLS FROM A HUMAN-COLON CARCINOMA
    ALITALO, K
    SCHWAB, M
    LIN, CC
    VARMUS, HE
    BISHOP, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (06): : 1707 - 1711
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] COHEN S, 1982, J BIOL CHEM, V257, P1523
  • [4] ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT
    EVAN, GI
    LEWIS, GK
    RAMSAY, G
    BISHOP, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3610 - 3616
  • [5] FURTH ME, 1987, ONCOGENE, V1, P47
  • [6] GULLICK WJ, 1986, CANCER RES, V46, P285
  • [7] EXPRESSION OF THE C-ERBB-2 PROTEIN IN NORMAL AND TRANSFORMED-CELLS
    GULLICK, WJ
    BERGER, MS
    BENNETT, PLP
    ROTHBARD, JB
    WATERFIELD, MD
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (02) : 246 - 254
  • [8] GULLICK WJ, 1989, MOL BIOL CANCER, P38
  • [9] P185HER2 MONOCLONAL-ANTIBODY HAS ANTIPROLIFERATIVE EFFECTS INVITRO AND SENSITIZES HUMAN-BREAST TUMOR-CELLS TO TUMOR NECROSIS FACTOR
    HUDZIAK, RM
    LEWIS, GD
    WINGET, M
    FENDLY, BM
    SHEPARD, HM
    ULLRICH, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) : 1165 - 1172
  • [10] KAHN P, 1988, ONCOGENES GROWTH CON